UNSPSC 51201819: Sargramostim

This classification denotes a therapeutic granulocyte-macrophage colony-stimulating factor with the molecular formula C639H1006N168O196S8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5TAA004E22, more generally known as sargramostim. European Medicines Agency schedules sargramostim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10450MIG. The term SARGRAMOSTIM is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 6, no, 3 1992, list 32.

UNSPSC 51201819 Sargramostim is a Commodity code for a specific biopharmaceutical product, but the single recent state-local opportunity posted under it involves Yellow Fever Vaccine procurement, not sargramostim. The Mississippi State Department of Health posted a sole source notice on July 13, 2026 for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026. This mismatch suggests the code may be misapplied in the source system or that the opportunity was tagged incorrectly. State and local health departments use UNSPSC codes to classify pharmaceutical and vaccine purchases, but the specificity of the Commodity tier often leads to indexing inconsistencies when a particular product is in high demand or when procurement offices adapt their taxonomies to available inventory.

The code shows minimal recent relevant activity in state and local procurement databases. Beyond the single Mississippi Department of Health notice, no other opportunities appear under UNSPSC 51201819 in the available records. Without additional opportunities to characterize the issuing-body mix, geographic spread, or procurement patterns, the code presents limited visibility into active state and local demand. Firms pursuing pharmaceutical or vaccine supply contracts should monitor health department solicitations broadly rather than rely on this Commodity code as a reliable filter, and should verify code assignments in notices before submitting responses.